[PITUITARY AND ADRENAL RESERVE FOLLOWING PROLONGED ADRENOCORTICAL THERAPY. PRELIMINARY COMMUNICATION].
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D003142:Communication; D004358:Drug Therapy; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010600:Pharmacology; D010900:Pituitary Diseases; D010902:Pituitary Gland; D010912:Pituitary-Adrenal Function Tests
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ADRENAL CORTEX HORMONES; ALDOSTERONE ANTAGONISTS; CORTICOTROPIN; DRUG THERAPY; KETONES; METYRAPONE; PHARMACOLOGY; PITUITARY GLAND; PITUITARY-ADRENAL FUNCTION TESTS
REZERWA PRZYSADKOWA I NADNERCZOWA U CHORYCH LECZONYCH DLUGOTRWALE HORMONAMI KORY NADNERCZA.